Long-term vitamin D3 supplementation does not prevent colonic inflammation or modulate bone health in il-10 knockout mice at young adulthood

Nutrients

Volumn 6, Issue 9, 2014, Pages 3847-3862

  Glenn, Andrea J ^a   Fielding, Kristina A ^a   Chen, Jianmin ^a   Comelli, Elena M ^a   Ward, Wendy E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

Bone mineral density; Bone strength; Intestinal inflammation; Mice; Vitamin D

Indexed keywords

CALCITRIOL RECEPTOR; COLECALCIFEROL; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA; BONE DENSITY CONSERVATION AGENT; VITAMIN; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE STRENGTH; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; KNOCKOUT MOUSE; MALE; MATING; MICROARRAY ANALYSIS; MORPHOMETRICS; MOUSE; NONHUMAN; PROGENY; RNA EXTRACTION; VITAMIN SUPPLEMENTATION; WEANING; WEIGHT GAIN; ANIMAL; BLOOD; BONE; COLON; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; FEMUR; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; COLON; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE, KNOCKOUT; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMINS;

EID: 84908136959     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6093847     Document Type: Article

References (34)

1. Sartor, R.B. Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3, 390-407.
2. Sanchez-Munoz, F.; Dominguez-Lopez, A.; Yamamoto-Furusho, J.K. Role of cytokines in inflammatory bowel disease. World J. Gastroenterol. 2008, 14, 4280-4288.
3. Kwan Tat, S.; Padrines, M.; Theoleyre, S.; Heymann, D.; Fortun, Y. IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15, 49-60.
4. Van Hogezand, R.A.; Hamdy, N.A. Skeletal morbidity in inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 2006, 41, 59-64.
5. Wong, S.C.; Catto-Smith, A.G.; Zacharin, M. Pathological fractures in paediatric patients with inflammatory bowel disease. Eur. J. Pediatr. 2014, 173, 141-151.
6. Madsen, K.L. Inflammatory bowel disease: Lessons from the IL-10 gene-deficient mouse. Clin. Investig. Med. 2001, 24, 250-257.
7. Kuhn, R.; Lohler, J.; Rennick, D.; Rajewsky, K.; Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75, 263-274.
8. Cohen, S.L.; Moore, A.M.; Ward, W.E. Interleukin-10 knockout mouse: A model for studying bone metabolism during intestinal inflammation. Inflamm. Bowel Dis. 2004, 10, 557-563.
9. Ardizzone, S.; Cassinotti, A.; Bevilacqua, M.; Clerici, M.; Porro, G.B. Vitamin D and inflammatory bowel disease. Vitam. Horm. 2011, 86, 367-377.
10. Pappa, H.M.; Grand, R.J.; Gordon, C.M. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm. Bowel Dis. 2006, 12, 1162-1174.
11. Dusso, A.S.; Brown, A.J.; Slatopolsky, E. Vitamin D. Am. J. Physiol. Ren. Physiol. 2005, 289, F8-F28.
12. 3 target genes. Mol. Endocrinol. 2005, 19, 2685-2695.
13. 3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol. 2012, 12, 57.
14. 3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G1299-G1311.
15. Bergstrand, O.; Hellers, G. Breast-feeding during infancy in patients who later develop Crohn's disease. Scand. J. Gastroenterol. 1983, 18, 903-906.
16. Angelucci, E.; Cocco, A.; Cesarini, M.; Crudeli, A.; Necozione, S.; Caprilli, R.; Latella, G. Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am. J. Gastroenterol. 2009, 104, 1608-1609.
17. Lagishetty, V.; Misharin, A.V.; Liu, N.Q.; Lisse, T.S.; Chun, R.F.; Ouyang, Y.; McLachlan, S.M.; Adams, J.S.; Hewison, M. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 2010, 151, 2423-2432.
18. Ooi, J.H.; Li, Y.; Rogers, C.J.; Cantorna, M.T. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J. Nutr. 2013, 143, 1679-1686.
19. Froicu, M.; Zhu, Y.; Cantorna, M.T. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 2006, 117, 310-318.
20. Cantorna, M.T.; Munsick, C.; Bemiss, C.; Mahon, B.D. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 2000, 130, 2648-2652.
21. Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals; Ernest, D., Olfert, D.V.M., Brenda, M., Cross, D.V.M., McWilliam, A., Eds.; Canadian Council on Animal Care: Ottawa, ON, Canada, 1993; Volume 1, pp. 1-212.
22. Fleet, J.C.; Gliniak, C.; Zhang, Z.; Xue, Y.; Smith, K.B.; McCreedy, R.; Adedokun, S.A. Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J. Nutr. 2008, 138, 1114-1120.
23. Allred, D.C.; Harvey, J.M.; Berardo, M.; Clark, G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 1998, 11, 155-168.
24. Cohen, S.L.; Moore, A.M.; Ward, W.E. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. J. Nutr. Biochem. 2005, 16, 368-374.
25. R Project for Statistical Computing, Version 2.14.1. Available online: http://www.r-project.org/ (accessed on 17 September 2014).
26. Gene Expression Omnibus. Available online: http://www.ncbi.nlm.nih.gov/geo/ (accessed on 15 September 2014).
27. Kaludjerovic, J.; Ward, W.E. Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice. J. Nutr. 2009, 139, 467-473.
28. Lagunova, Z.; Porojnicu, A.C.; Vieth, R.; Lindberg, F.A.; Hexeberg, S.; Moan, J. Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J. Nutr. 2011, 141, 112-117.
29. Mathieu, C.; van Etten, E.; Gysemans, C.; Decallonne, B.; Kato, S.; Laureys, J.; Depovere, J.; Valckx, D.; Verstuyf, A.; Bouillon, R. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res. 2001, 16, 2057-2065.
30. Reiff, C.; Delday, M.; Rucklidge, G.; Reid, M.; Duncan, G.; Wohlgemuth, S.; Hormannsperger, G.; Loh, G.; Blaut, M.; Collie-Duguid, E. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm. Bowel Dis. 2009, 15, 1721-1736.
31. Dresner-Pollak, R.; Gelb, N.; Rachmilewitz, D.; Karmeli, F.; Weinreb, M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 2004, 127, 792-801.
32. Reeves, P.G.; Rossow, K.L.; Lindlauf, J. Development and testing of the AIN-93 purified diets for rodents: Results on growth, kidney calcification and bone mineralization in rats and mice. J. Nutr. 1993, 123, 1923-1931.
33. 3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, G35-G46.
34. Spelling, P.; Bonfa, E.; Caparbo, V.F.; Pereira, R.M. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: A bone damage biomarker? Scand. J. Rheumatol. 2008, 37, 439-444.